Novocure’s device shown to slow cancer progression in the brain in trial
Novocure’s therapy met the main goal of a late-stage trial of slowing the progression of cancer to the brain in patients with a type of lung cancer, the company said.
Novocure’s therapy met the main goal of a late-stage trial of slowing the progression of cancer to the brain in patients with a type of lung cancer, the company said.
APCCC 2024 ideal sequence after ADT alone or ADT + ARPI for treatment in the metastatic hormone sensitive prostate cancer (mHSPC) setting, NCCN prostate cancer…
APCCC 2024 tumor genomic profiling in advanced prostate cancer, prostate cancer biopsies, clonal hematopoiesis of indeterminate potential (CHiP), Prostate Cancer Precision Medicine Multi-Institutional Collaborative Effort…
Regret after gender-affirming surgery (GAS) is a complex issue. Comparing regret after GAS to regret after plastic surgery operations and other major life decisions is…
A former McKinsey & Co partner sued the global consulting firm on Friday and accused it of defaming him and making him a “scapegoat” to…
Staff at CVS Health’s unit Omnicare in Las Vegas voted to join the Pharmacy Guild, becoming the first location at the national pharmacy chain to…
Bayer CEO Bill Anderson on Friday won a vote of confidence at his first annual general meeting (AGM) at the helm of the embattled healthcare…
A former McKinsey & Co partner sued the global consulting firm on Friday and accused it of defaming him and making him a “scapegoat” to…
Staff at CVS Health’s unit Omnicare in Las Vegas voted to join the Pharmacy Guild, becoming the first location at the national pharmacy chain to…
Bayer CEO Bill Anderson on Friday won a vote of confidence at his first annual general meeting (AGM) at the helm of the embattled healthcare…
HCA Healthcare on Friday beat Wall Street estimates for quarterly profit and revenue but left its annual forecast unchanged, sending shares of the largest for-profit…